SCHEMBL337701

SCHEMBL337701

CC(=O)Oc1ccc(C(C)(C)C)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.59
TDP1 Q9NUW8 2/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
LMNA P02545 3/20 0.59
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
NPC1 O15118 1/20 0.54
HTT P42858 1/20 0.54
POLB P06746 1/20 0.53
PKM P14618 1/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
NPSR1 Q6W5P4 2/20 0.53
ELANE P08246 1/20 0.52
ALDH1A1 P00352 3/20 0.50
HSD17B10 Q99714 2/20 0.50
THRB P10828 1/20 0.50
PRSS1 P07477 1/20 0.49
ACR P10323 1/20 0.49
ALOX15 P16050 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL22832179 0.98 MAPT (0.58) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL13415734 0.89 MAPT (0.50) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL547684 0.89 MAPT (0.50) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL16576513 0.89 MAPT (0.50) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL15095779 0.88 MAPT (0.61) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL3668943 0.87 MAPT (0.65) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL5491320 0.87 LMNA (0.59) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL10629411 0.87 LMNA (0.59) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL1507621 0.87 LMNA (0.59) MAPTTDP1L3MBTL1LMNARAB9A
SCHEMBL11422436 0.85 LMNA (0.57) MAPTTDP1L3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117897439-A Method for screening solvent for extraction of polyvinyl chloride, method for recovering waste material, and recovered polyvinyl chloride and composition 株式会社LG化学 2024-04-16 CN claimed
CN-116904764-A Method and device for selectively extracting lithium from lithium-containing alkaline aqueous solution 北京科技大学 2023-10-20 CN claimed
CN-116904765-A Method for selectively extracting, precipitating and enriching lithium from lithium-containing alkaline aqueous solution 北京科技大学 2023-10-20 CN claimed
CN-102977098-B Aryl-substituted indolizine derivative and preparation method and applications thereof UNIV SHAOXING 2015-04-01 CN claimed
CN-103923765-A Detergent Composition For Process Of Manufacturing Semiconductors And Displays COWON INNOTECH INC 2014-07-16 CN claimed
CN-102977098-A Aryl-substituted indolizine derivative and preparation method and applications thereof UNIV SHAOXING 2013-03-20 CN claimed
CN-1893910-A Cyclic siloxane compositions for active ingredient release GEN ELECTRIC (US) 2007-01-10 CN claimed
JP-58083650-A None JP disclosed
EP-3790985-B1 METHODS OF SYNTHESIZING A POLYNUCLEOTIDE ARRAY USING PHOTACTIVATED AGENTS VIBRANT HOLDINGS LLC (US) 2026-04-15 EP disclosed
US-20250263430-A1 METHODS OF SYNTHESIZING A POLYNUCLEOTIDE ARRAY USING PHOTOACTIVATED AGENTS VIBRANT HOLDINGS, LLC 2025-08-21 US disclosed
US-12351924-B2 Electroreductive cross coupling OHIO STATE INNOVATION FOUNDATION (US) 2025-07-08 US disclosed
US-12319712-B2 Methods of synthesizing a polynucleotide array using photoactivated agents VIBRANT HOLDINGS, LLC (US) 2025-06-03 US disclosed
WO-2025019587-A1 SENOTHERAPEUTIC COMPOUNDS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2025-01-23 WO disclosed
EP-0267048-A2 Peroxyacids, phenoxyacetate peracid precursors and perhydrolysis system The Clorox Company (US) 1988-05-11 EP disclosed
EP-0146297-B1 SUBSTITUTED TRANS-1,2-DIAMINOCYCLOHEXYL AMIDE COMPOUNDS WARNER-LAMBERT COMPANY (US) 1988-02-03 EP disclosed
US-4677122-A ANALGESICS, DIURETICS WARNER-LAMBERT COMPANY (US) 1987-06-30 US disclosed
US-4598087-A DIURETICS; ANALGESICS, PSYCHOTHERAPEUTICS WARNER-LAMBERT COMPANY (US) 1986-07-01 US disclosed
EP-0146297-A1 Substituted trans-1,2-diaminocyclohexyl amide compounds WARNER-LAMBERT COMPANY (US) 1985-06-26 EP disclosed
US-4490552-A Preparation of aryl esters by decomposing an aryl thallium carboxylate RUTGERSWERKE AG (DE) 1984-12-25 US disclosed
JP-S5883650-A ACYLOXYNEOPHYL CHLORIDE AND ITS PREPARATION MITSUI TOATSU CHEM INC 1983-05-19 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250263430-A1 METHODS OF SYNTHESIZING A POLYNUCLEOTIDE ARRAY USING PHOTOACTIVATED AGENTS POLN, PCNA, POLM MAPT 3080/4885TDP1 95/4885L3MBTL1 1590/4885
US-12319712-B2 Methods of synthesizing a polynucleotide array using photoactivated agents POLN, PCNA, POLM MAPT 3080/4885TDP1 95/4885L3MBTL1 1590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.